06 Dec ConjuGon to receive $1.2 million in defense dollars
Madison, Wis. – As antibiotic resistance worsens, new therapeutics are needed, and a Madison company that is developing fundamentally new technologies to combat antibiotic-resistant bacteria will receive a financial boost from the federal government, according to the Milwaukee Business Journal.
ConjuGon Inc. has been awarded $1.2 million from the U.S. Department of Defense in 2008 to help fund the development of a novel wound infection treatment product.
The funds are included in the fiscal year 2008 defense appropriations bill, which was signed into law by President Bush on Nov. 13. U.S. Rep. Tammy Baldwin, D-Madison, helped secure the funds for ConjuGon.
• ConjuGon raises $3.3 million to fund clinical trials
• ConjuGon gets $730K to treat infections
• ConjuGon lands $1 million angel investment